Advances in Quantitative Coronary Arteriography

Front Matter....Pages i-xvi
Front Matter....Pages 1-1
A Pathologist’s view of quantitative coronary arteriography....Pages 3-14
Angioscopy versus angiography for the detection of coronary artery disease surface morphology....Pages 15-27
Development and application of coronary intravascular ultrasound: comparison to quantitative angiography....Pages 29-51
Front Matter....Pages 53-53
Quantitative analysis of the cineangiogram: Why bother?....Pages 55-73
Quantitative coronary arteriography: equipment and technical requirements....Pages 75-111
The filmless catheterization laboratory: when will it be reality?....Pages 113-122
Front Matter....Pages 123-123
Optimal frame selection for QCA....Pages 125-135
Variability of QCA-core laboratory assessments of coronary anatomy....Pages 137-159
Automated physical assessment of image quality in digital cardiac imaging....Pages 161-176
Experiences of a quantitative coronary angiographic core laboratory in restenosis prevention trials....Pages 177-192
Front Matter....Pages 193-193
Flow and flow reserve by parametric imaging....Pages 195-211
Maximal myocardial perfusion as a measure of the functional significance of coronary artery disease....Pages 213-233
Angiographic measurement of coronary blood flow....Pages 235-252
Front Matter....Pages 253-253
Value and limitations of quantitative coronary angiography to assess progression or regression of coronary atherosclerosis....Pages 255-271
The impact of the calcium antagonist nifedipine on the angiographic progression of coronary artery disease: Results of the INTACT (international nifedipine trial on antiatherosclerotic therapy)....Pages 273-284
Progression and regression of coronary atherosclerosis: data from a controlled clinical trial with nicardipine....Pages 285-298
Computer quantitative measurements of CLAS coronary angiograms compared to evaluation by panels of human angiographers....Pages 299-310
A maximum confidence strategy for measuring progression and regression of coronary artery disease in clinical trials....Pages 311-326
Front Matter....Pages 327-327
Pharmacological prevention of restenosis after percutaneous transluminal coronary angioplasty [PTCA]: overview and methodological considerations....Pages 329-350
CARPORT — Coronary artery restenosis prevention on repeated thromboxane antagonism. A multicenter randomized clinical trial....Pages 351-364
Front Matter....Pages 327-327
Angiotensin converting enzyme inhibition in the prevention of restenosis: the MERCATOR and MARCATOR trials....Pages 365-372
Historic. A multicenter randomized clinical trial to evaluate feasibility and tolerability of recombinant congener of hirudin as an alternative to heparin during PTCA....Pages 373-376
Angiopeptin in experimental models of restenosis....Pages 377-383
Cyclic flow alterations and neointimal proliferation following experimental coronary stenosis and endothelial injury....Pages 385-393
Front Matter....Pages 395-395
The use of quantitative coronary angiography (QCA) in interventional cardiology....Pages 397-441
Quantitative coronary arteriography in laser balloon angioplasty....Pages 443-458
Quantitative coronary angiography after directional coronary atherectomy....Pages 459-472
Directional coronary atherectomy: evaluation by quantitative angiography....Pages 473-484
Quantitative results and lesion morphology in coronary excimer laser angioplasty....Pages 485-495
Percutaneous transluminal coronary rotational ablation: early follow-up at 24 hours by quantitative angiography....Pages 497-513
Quantitative assessment of the residual stenosis after percutaneous transluminal cororonary rotary ablation: European Experience....Pages 515-523
Quantitative coronary angiography after revascularization with the transluminal extraction-endarterectomy catheter (TEC TM )....Pages 525-533
Front Matter....Pages 535-535
An experimental cardiologist’s view on coronary stents....Pages 537-552
The Palmaz-Schatz TM stent....Pages 553-566
The Wallstent experience: 1986–1990....Pages 567-591
Immediate and long-term clinical and angiographic results following Wiktor TM stent implantation in patients with documented restenosis of a native coronary artery lesion following prior balloon angioplasty....Pages 593-607
Coronary Gianturco-Roubin stents....Pages 609-624
Back Matter....Pages 625-640